Nucleoside transporters in the disposition and targeting of nucleoside analogs in the kidney

European Journal of Pharmacology

Volumn 479, Issue 1-3, 2003, Pages 269-281

  Mangravite, Lara M ^a   Badagnani, Ilaria ^a   Giacomini, Kathleen M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Drug disposition; Kidney; Localization; Nucleoside analog; Nucleoside transporter; Renal cancer

Indexed keywords

ADENOSINE DEOXYADENOSINE; CARRIER PROTEIN; CONCENTRATIVE NUCLEOSIDE TRANSPORTER 1; CONCENTRATIVE NUCLEOSIDE TRANSPORTER 2; CONCENTRATIVE NUCLEOSIDE TRANSPORTER 3; CYTARABINE; DIDANOSINE; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 2; GEMCITABINE; NUCLEOSIDE; NUCLEOSIDE ANALOG; RIBAVIRIN; SOLUTE CARRIER 28A1; SOLUTE CARRIER 28A2; SOLUTE CARRIER 28A3; SOLUTE CARRIER 29A1; SOLUTE CARRIER 29A2; UNCLASSIFIED DRUG; ZIDOVUDINE;

ACUTE LYMPHOCYTIC LEUKEMIA; ACUTE NONLYMPHOCYTIC LEUKEMIA; APICAL MEMBRANE; BLADDER CANCER; BREAST CANCER; CANCER CHEMOTHERAPY; CHRONIC LYMPHATIC LEUKEMIA; DIFFUSION; DRUG PROTEIN BINDING; DRUG TARGETING; HEART ARRHYTHMIA; HEMATURIA; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY; KIDNEY EPITHELIUM; KIDNEY FAILURE; KIDNEY TUMOR; LEUKEMIC MENINGITIS; LUNG NON SMALL CELL CANCER; NEPHROLITHIASIS; NEPHROTOXICITY; NONHUMAN; NUCLEOSIDE TRANSPORT; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEINURIA; REVIEW;

EID: 0242637653     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2003.08.076     Document Type: Article

References (81)

1. Aapro M.S., Martin C., Hatty S. Gemcitabine - a safety review. Anticancer Drugs. 9:1998;191-201.
2. Abbruzzese J.L., Grunewald R., Weeks E.A., Gravel D., Adams T., Nowak B., Mineishi S., Tarassoff P., Satterlee W., Raber M.N., Plunkett W. A phase I clinical, plasma, and cellular pharmacology study of gemcitabine. J. Clin. Oncol. 9:1991;491-498.
3. +-nucleoside cotransporter. J. Biol. Chem. 270:1995;13596-13599.
4. Coe I., Zhang Y., McKenzie T., Naydenova Z. PKC regulation of the human equilibrative nucleoside transporter, hENT1. FEBS Lett. 517:2002;201-205.
5. Crawford C.R., Cass C.E., Young J.D., Belt J.A. Stable expression of a recombinant sodium-dependent, pyrimidine-selective nucleoside transporter (CNT1) in a transport-deficient mouse leukemia cell line. Biochem. Cell. Biol. 76:1998;843-851.
6. Crawford C.R., Patel D.H., Naeve C., Belt J.A. Cloning of the human equilibrative, nitrobenzylmercaptopurine riboside (NBMPR)-insensitive nucleoside transporter ei by functional expression in a transport-deficient cell line. J. Biol. Chem. 273:1998;5288-5293.
7. Crowther M.A., Callaghan W., Hodsman A.B., Mackie I.C. Dideoxyinosine-associated nephrotoxicity. Aids. 7:1993;131-132.
8. de Miranda P., Good S.S., Yarchoan R., Thomas R.V., Blum M.R., Myers C.E., Broder S. Alteration of zidovudine pharmacokinetics by probenecid in patients with AIDS or AIDS-related complex. Clin. Pharmacol. Ther. 46:1989;494-500.
9. Dresser M.J., Gerstin K.M., Gray A.T., Loo D.D., Giacomini K.M. Electrophysiological analysis of the substrate selectivity of a sodium-coupled nucleoside transporter (rCNT1) expressed in Xenopus laevis oocytes. Drug Metab. Dispos. 28:2000;1135-1140.
10. Fang X., Parkinson F.E., Mowles D.A., Young J.D., Cass C.E. Functional characterization of a recombinant sodium-dependent nucleoside transporter with selectivity for pyrimidine nucleosides (cNT1rat) by transient expression in cultured mammalian cells. Biochem. J. 317(Pt. 2):1996;457-465.
11. +-dependent nucleoside transport in liver: two different isoforms from the same gene family are expressed in liver cells. Biochem. J. 330:1998;997-1001.
12. Fontana R.J. Uric acid nephrolithiasis associated with interferon and ribavirin treatment of hepatitis C. Dig. Dis. Sci. 46:2001;920-924.
13. Gati W.P., Paterson A.R., Belch A.R., Chlumecky V., Larratt L.M., Mant M.J., Turner A.R. Es nucleoside transporter content of acute leukemia cells: role in cell sensitivity to cytarabine (araC). Leuk. Lymphoma. 32:1998;45-54.
14. Gerstin K.M., Dresser M.J., Giacomini K.M. Specificity of human and rat orthologs of the concentrative nucleoside transporter, SPNT. Am. J. Physiol., Renal. Physiol. 283:2002;F344-F349.
15. + nucleoside cotransport system (N2) in Xenopus laevis oocytes. Pflugers Arch. 427:1994;381-383.
16. Godley P.A., Taylor M. Renal cell carcinoma. Curr. Opin. Oncol. 13:2001;199-203.
17. Gourdeau H., Clarke M.L., Ouellet F., Mowles D., Selner M., Richard A., Lee N., Mackey J.R., Young J.D., Jolivet J., Lafreniere R.G., Cass C.E. Mechanisms of uptake and resistance to troxacitabine, a novel deoxycytidine nucleoside analogue, in human leukemic and solid tumor cell lines. Cancer Res. 61:2001;7217-7224.
18. Graham K.A., Leithoff J., Coe I.R., Mowles D., Mackey J.R., Young J.D., Cass C.E. Differential transport of cytosine-containing nucleosides by recombinant human concentrative nucleoside transporter protein hCNT1. Nucleosides Nucleotides Nucleic Acids. 19:2000;415-434.
19. Griffiths M., Beaumont N., Yao S.Y., Sundaram M., Boumah C.E., Davies A., Kwong F.Y., Coe I., Cass C.E., Young J.D., Baldwin S.A. Cloning of a human nucleoside transporter implicated in the cellular uptake of adenosine and chemotherapeutic drugs. Nat. Med. 3:1997;89-93.
20. Griffiths M., Yao S.Y., Abidi F., Phillips S.E., Cass C.E., Young J.D., Baldwin S.A. Molecular cloning and characterization of a nitrobenzylthioinosine- insensitive (ei) equilibrative nucleoside transporter from human placenta. Biochem. J. 328:1997;739-743.
21. + nucleoside transport in brush border membrane vesicles from human kidney. Biochim. Biophys. Acta. 1149:1993;202-208.
22. Gutierrez M.M., Giacomini K.M. Expression of a human renal sodium nucleoside cotransporter in Xenopus laevis oocytes. Biochem. Pharmacol. 48:1994;2251-2253.
23. Gutierrez M.M., Brett C.M., Ott R.J., Hui A.C., Giacomini K.M. Nucleoside transport in brush border membrane vesicles from human kidney. Biochim. Biophys. Acta. 1105:1992;1-9.
24. + nucleoside cotransporter rCNT1. J. Biol. Chem. 276:2001;27981- 27988.
25. Hammond J.R. Interaction of a series of draflazine analogues with equilibrative nucleoside transporters: species differences and transporter subtype selectivity. Naunyn-Schmiedeberg's Arch. Pharmacol. 361:2000;373-382.
26. Hartman N.R., Yarchoan R., Pluda J.M., Thomas R.V., Marczyk K.S., Broder S., Johns D.G. Pharmacokinetics of 2′,3′-dideoxyadenosine and 2′,3′-dideoxyinosine in patients with severe human immunodeficiency virus infection. Clin. Pharmacol. Ther. 47:1990;647-654.
27. Huang Q.Q., Yao S.Y., Ritzel M.W., Paterson A.R., Cass C.E., Young J.D. Cloning and functional expression of a complementary DNA encoding a mammalian nucleoside transport protein. J. Biol. Chem. 269:1994;17757-17760.
28. Hyde R.J., Cass C.E., Young J.D., Baldwin S.A. The ENT family of eukaryote nucleoside and nucleobase transporters: recent advances in the investigation of structure/function relationships and the identification of novel isoforms. Mol. Membr. Biol. 18:2001;53-63.
29. Knupp C.A., Shyu W.C., Dolin R., Valentine F.T., McLaren C., Martin R.R., Pittman K.A., Barbhaiya R.H. Pharmacokinetics of didanosine in patients with acquired immunodeficiency syndrome or acquired immunodeficiency syndrome-related complex. Clin. Pharmacol. Ther. 49:1991;523-535.
30. Kuttesch J.F. Jr., Nelson J.A. Renal handling of 2′-deoxyadenosine and adenosine in humans and mice. Cancer Chemother. Pharmacol. 8:1982;221-229.
31. Lai Y., Bakken A.D., Unadkat J.D. Simultaneous expression of hCNT1-CFP and hENT1-YFP in Mardin-Darby canine kidney (MDCK) cells: localization and vectorial transport studies. J. Biol. Chem. 277(40):2002;37711-37717.
32. Leabman M.K., Huang C.C., DeYoung J., Carlson E.J., Taylor T.R., De La Cruz M., Johns S.J., Stryke D., Kawamoto M., Urban T.J., Kroetz D.L., Ferrin T.E., Clark A.G., Risch N., Herskowitz I., Giacomini K.M. Natural variation in human membrane transporter genes reveals evolutionary and functional constraints. Proc. Natl. Acad. Sci. U. S. A. 100:2003;5896-5901.
33. + dependent uridine carriers. Am. J. Physiol. 258:1990;F1203-F1210.
34. Le Hir M., Dubach U.C. Sodium gradient-energized concentrative transport of adenosine in renal brush border vesicles. Pflugers Arch. 401:1984;58-63.
35. + nucleoside transporter CNT2 cloned from rat blood-brain barrier. J. Pharmacol. Exp. Ther. 299:2001;735-740.
36. + nucleoside cotransporters hCNT1 and hCNT2. J. Biol. Chem. 274:1999;24475-24484.
37. Lostao M.P., Mata J.F., Larrayoz I.M., Inzillo S.M., Casado F.J., Pastor-Anglada M. Electrogenic uptake of nucleosides and nucleoside-derived drugs by the human nucleoside transporter 1 (hCNT1) expressed in Xenopus laevis oocytes. FEBS Lett. 481:2000;137-140.
38. Lum P.Y., Ngo L.Y., Bakken A.H., Unadkat J.D. Human intestinal es nucleoside transporter: molecular characterization and nucleoside inhibitory profiles. Cancer Chemother. Pharmacol. 45:2000;273-278.
39. Mackey J.R., Mani R.S., Selner M., Mowles D., Young J.D., Belt J.A., Crawford C.R., Cass C.E. Functional nucleoside transporters are required for gemcitabine influx and manifestation of toxicity in cancer cell lines. Cancer Res. 58:1998;4349-4357.
40. Mackey J.R., Yao S.Y., Smith K.M., Karpinski E., Baldwin S.A., Cass C.E., Young J.D. Gemcitabine transport in xenopus oocytes expressing recombinant plasma membrane mammalian nucleoside transporters. J. Natl. Cancer Inst. 91:1999;1876-1881.
41. Mackey J.R., Jennings L.L., Clarke M.L., Santos C.L., Dabbagh L., Vsianska M., Koski S.L., Coupland R.W., Baldwin S.A., Young J.D., Cass C.E. Immunohistochemical variation of human equilibrative nucleoside transporter 1 protein in primary breast cancers. Clin. Cancer Res. 8:2002;100-106.
42. Mangravite L.M., Lipschutz J.H., Mostov K.E., Giacomini K.M. Localization of GFP-tagged concentrative nucleoside transporters in a renal polarized epithelial cell line. Am. J. Physiol., Renal Physiol. 280:2001;F879-F885.
43. Mangravite L.M., Xiao G., Giacomini K.M. Localization of human equilibrative nucleoside transporters, hENT1 and hENT2, in renal epithelial cells. Am. J. Physiol., Renal Physiol. 284:2003;F902-F910.
44. Mata J.F., Garcia-Manteiga J.M., Lostao M.P., Fernandez-Veledo S., Guillen-Gomez E., Larrayoz I.M., Lloberas J., Casado F.J., Pastor-Anglada M. Role of the human concentrative nucleoside transporter (hCNT1) in the cytotoxic action of 5′-deoxy-5-fluorouridine, an active intermediate metabolite of capecitabine, a novel oral anticancer drug. Mol. Pharmacol. 59:2001;1542-1548.
45. Molina-Arcas M., Bellosillo B., Casado F.J., Montserrat E., Gil J., Colomer D., Pastor-Anglada M. Fludarabine uptake mechanisms in B-cell chronic lymphocytic leukemia. Blood. 101:2003;2328-2334.
46. Osato D.H., Huang C.C., Kawamoto M., Johns S.J., Stryke D., Wang J., Ferrin T.E., Herskowitz I., Giacomini K.M. Functional characterization in yeast of genetic variants in the human equilibrative nucleoside transporter, ENT1. Pharmacogenetics. 13:2003;297-301.
47. Parodi J., Flores C., Aguayo C., Rudolph M.I., Casanello P., Sobrevia L. Inhibition of nitrobenzylthioinosine-sensitive adenosine transport by elevated D-glucose involves activation of P2Y2 purinoceptors in human umbilical vein endothelial cells. Circ. Res. 90:2002;570-577.
48. Paroni R., Del Puppo M., Borghi C., Sirtori C.R., Galli Kienle M. Pharmacokinetics of ribavirin and urinary excretion of the major metabolite 1,2,4-triazole-3-carboxamide in normal volunteers. Int. J. Clin. Pharmacol. Ther. Toxicol. 27:1989;302-307.
49. + nucleoside purine (N1) transporter. Pharm. Res. 15:1998;950-952.
50. Pennycooke M., Chaudary N., Shuralyova I., Zhang Y., Coe I.R. Differential expression of human nucleoside transporters in normal and tumor tissue. Biochem. Biophys. Res. Commun. 280:2001;951-959.
51. Reiman T., Clarke M.L., Dabbagh L., Vsianska M., Coupland R.W., Belch A.R., Baldwin S.A., Young J.D., Cass C.E., Mackey J.R. Differential expression of human equilibrative nucleoside transporter 1 (hENT1) protein in the Reed-Sternberg cells of Hodgkin's disease. Leuk. Lymphoma. 43:2002;1435-1440.
52. + nucleoside cotransporter (hCNT1). Am. J. Physiol. 272:1997;C707-C714.
53. +/nucleoside cotransporter (hCNT2) selective for purine nucleosides and uridine. Mol. Membr. Biol. 15:1998;203-211.
54. + nucleoside cotransporter proteins (hCNT3 and mCNT3) broadly selective for purine and pyrimidine nucleosides (system cib). J. Biol. Chem. 276:2001;2914-2927.
55. Schaner M.E., Wang J., Zevin S., Gerstin K.M., Giacomini K.M. Transient expression of a purine-selective nucleoside transporter (SPNTint) in a human cell line (HeLa). Pharm. Res. 14:1997;1316-1321.
56. SenGupta D.J., Lum P.Y., Lai Y., Shubochkina E., Bakken A.H., Schneider G., Unadkat J.D. A single glycine mutation in the equilibrative nucleoside transporter gene, hENT1, alters nucleoside transport activity and sensitivity to nitrobenzylthioinosine. Biochemistry. 41:2002;1512-1519.
57. Slavin R.E., Dias M.A., Saral R. Cytosine arabinoside induced gastrointestinal toxic alterations in sequential chemotherapeutic protocols: a clinical-pathologic study of 33 patients. Cancer. 42:1978;1747-1759.
58. Soler C., Garcia-Manteiga J., Valdes R., Xaus J., Comalada M., Casado F.J., Pastor-Anglada M., Celada A., Felipe A. Macrophages require different nucleoside transport systems for proliferation and activation. FASEB J. 15:2001;1979-1988.
59. Spielman W.S., Arend L.J. Adenosine receptors and signaling in the kidney. Hypertension. 17:1991;117-130.
60. Stam R.W., den Boer M.L., Meijerink J.P., Ebus M.E., Peters G.J., Noordhuis P., Janka-Schaub G.E., Armstrong S.A., Korsmeyer S.J., Pieters R. Differential mRNA expression of Ara-C-metabolizing enzymes explains Ara-C sensitivity in MLL gene-rearranged infant acute lymphoblastic leukemia. Blood. 101:2003;1270-1276.
61. Sundaram M., Yao S.Y., Ng A.M., Griffiths M., Cass C.E., Baldwin S.A., Young J.D. Chimeric constructs between human and rat equilibrative nucleoside transporters (hENT1 and rENT1) reveal hENT1 structural domains interacting with coronary vasoactive drugs. J. Biol. Chem. 273:1998;21519-21525.
62. Sundaram M., Yao S.Y., Ingram J.C., Berry Z.A., Abidi F., Cass C.E., Baldwin S.A., Young J.D. Topology of a human equilibrative, nitrobenzylthioinosine (NBMPR)-sensitive nucleoside transporter (hENT1) implicated in the cellular uptake of adenosine and anti-cancer drugs. J. Biol. Chem. 276:2001;45270-45275.
63. Sundaram M., Yao S.Y., Ng A.M., Cass C.E., Baldwin S.A., Young J.D. Equilibrative nucleoside transporters: mapping regions of interaction for the substrate analogue nitrobenzylthioinosine (NBMPR) using rat chimeric proteins. Biochemistry. 40:2001;8146-8151.
64. Valdes R., Casado F.J., Pastor-Anglada M. Cell-cycle-dependent regulation of CNT1, a concentrative nucleoside transporter involved in the uptake of cell-cycle-dependent nucleoside-derived anticancer drugs. Biochem. Biophys. Res. Commun. 296:2002;575-579.
65. Vickers M.F., Mani R.S., Sundaram M., Hogue D.L., Young J.D., Baldwin S.A., Cass C.E. Functional production and reconstitution of the human equilibrative nucleoside transporter (hENT1) in Saccharomyces cerevisiae. Interaction of inhibitors of nucleoside transport with recombinant hENT1 and a glycosylation-defective derivative (hENT1/N48Q). Biochem. J. 339:1999;21-32.
66. Vickers M.F., Young J.D., Baldwin S.A., Ellison M.J., Cass C.E. Functional production of mammalian concentrative nucleoside transporters in Saccharomyces cerevisiae. Mol. Membr. Biol. 18:2001;73-79.
67. Vickers M.F., Kumar R., Visser F., Zhang J., Charania J., Raborn R.T., Baldwin S.A., Young J.D., Cass C.E. Comparison of the interaction of uridine, cytidine, and other pyrimidine nucleoside analogues with recombinant human equilibrative nucleoside transporter 2 (hENT2) produced in Saccharomyces cerevisiae. Biochem. Cell Biol. 80:2002;639-644.
68. + dependent nucleoside transporters. J. Biol. Chem. 272:1997;28845-28848.
69. + nucleoside transporter. Mol. Pharmacol. 55:1999;234-240.
70. + nucleoside transporter. J. Biol. Chem. 274:1999;2298-2302.
71. + dependent nucleoside transporters. Pharm. Res. 14:1997;1524-1532.
72. + dependent purine nucleoside transporter from human kidney: cloning and functional characterization. Am. J. Physiol. 273:1997;F1058-F1065.
73. Ward J.L., Sherali A., Mo Z.P., Tse C.M. Kinetic and pharmacological properties of cloned human equilibrative nucleoside transporters, ENT1 and ENT2, stably expressed in nucleoside transporter-deficient PK15 cells. Ent2 exhibits a low affinity for guanosine and cytidine but a high affinity for inosine. J. Biol. Chem. 275:2000;8375-8381.
74. + dependent purine and pyrimidine nucleoside transporters in bovine outer renal cortex brush-border-membrane vesicles. Biochem. Soc. Trans. 18:1990;684-685.
75. Williams T.C., Jarvis S.M. Multiple sodium-dependent nucleoside transport systems in bovine renal brush-border membrane vesicles. Biochem. J. 274:1991;27-33.
76. Williams T.C., Doherty A.J., Griffith D.A., Jarvis S.M. Characterization of sodium-dependent and sodium-independent nucleoside transport systems in rabbit brush-border and basolateral plasma-membrane vesicles from the renal outer cortex. Biochem. J. 264:1989;223-231.
77. Wright A.M., Paterson A.R., Sowa B., Akabutu J.J., Grundy P.E., Gati W.P. Cytotoxicity of 2-chlorodeoxyadenosine and arabinosylcytosine in leukaemic lymphoblasts from paediatric patients: significance of cellular nucleoside transporter content. Br. J. Haematol. 116:2002;528-537.
78. Wu X., Yuan G., Brett C.M., Hui A.C., Giacomini K.M. Sodium-dependent nucleoside transport in choroid plexus from rabbit. Evidence for a single transporter for purine and pyrimidine nucleosides. J. Biol. Chem. 267:1992;8813-8818.
79. Yao S.Y., Ng A.M., Muzyka W.R., Griffiths M., Cass C.E., Baldwin S.A., Young J.D. Molecular cloning and functional characterization of nitrobenzylthioinosine (NBMPR)-sensitive (es) and NBMPR-insensitive (ei) equilibrative nucleoside transporter proteins (rENT1 and rENT2) from rat tissues. J. Biol. Chem. 272:1997;28423-28430.
80. Yao S.Y., Ng A.M., Sundaram M., Cass C.E., Baldwin S.A., Young J.D. Transport of antiviral 3′-deoxy-nucleoside drugs by recombinant human and rat equilibrative, nitrobenzylthioinosine (NBMPR)-insensitive (ENT2) nucleoside transporter proteins produced in Xenopus oocytes. Mol. Membr. Biol. 18:2001;161-167.
81. Yao S.Y., Ng A.M., Vickers M.F., Sundaram M., Cass C.E., Baldwin S.A., Young J.D. Functional and molecular characterization of nucleobase transport by recombinant human and rat equilibrative nucleoside transporters 1 and 2. Chimeric constructs reveal a role for the ENT2 helix 5-6 region in nucleobase translocation. J. Biol. Chem. 277:2002;24938-24948.